M
Montai Health
AI-powered small molecule platform for developing therapies to treat chronic diseases using a vast collection of human-safe molecules
About Montai Health
Montai Health is a pharmaceutical company that is developing a new class of medicines to address chronic diseases. The company's approach is centered around its proprietary CONECTA platform, an AI-powered drug operating system that leverages a vast and curated dataset of 'Anthromolecules'. These are bioactive small molecules that have a long history of safe human consumption through foods and supplements.
Read full description
By analyzing these molecules, Montai Health aims to create predictably effective and safe therapies. The company's platform integrates biology, chemistry, and data science to unlock the therapeutic potential of these molecules. Montai Health is backed by a significant $50 million commitment from Flagship Pioneering, a life sciences innovation firm. The company's business model is focused on the research and development of novel drugs, with the ultimate goal of commercializing these therapies for patients with chronic illnesses. The target market is the global pharmaceutical industry, with a focus on chronic disease treatments.
At a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Cambridge, United States
- Employees
- 57
- Open positions
- None listed
- Dealroom signal
- 68.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Montai Health.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Dec 2022 | $50M | $200M | Flagship Pioneering | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Montai Health is 2.5K monthly website visits, down 10.7% over the last three months. Montai Health's team declined 5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Montai Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Montai Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








